Literature DB >> 16085207

Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program.

Antoinette Prouteau1, Hélène Verdoux, Catherine Briand, Alain Lesage, Pierre Lalonde, Luc Nicole, Daniel Reinharz, Emmanuel Stip.   

Abstract

The aims of this prospective study were to explore in subjects with psychosis participating in a rehabilitation program whether cognitive performances at baseline predicted (i) psychosocial functioning over a 15-16 month follow-up; (ii) improvement in psychosocial functioning over the rehabilitation program. Visuo-spatial tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB) were administered to assess cognitive performance in 55 subjects with schizophrenia spectrum disorders who completed a rehabilitation program. The Multnomah Community Ability Scale (MCAS) was used to measure dimensions of community functioning. One subscale of the Client's Assessment of Strengths, Interests, and Goals (CASIG) provided a measure of subjective quality of life (QoL). Improvement was defined as a 15% or more increase in psychosocial scores between baseline and follow-up. Worse baseline sustained attention predicted better self-rated quality of life, and better baseline visual memory predicted better community functioning over the rehabilitation follow-up period, in particular, higher autonomy in activities of daily living, and less physical and psychiatric symptoms that could interfere with rehabilitation. Baseline cognitive performances predicted community functioning improvement during the follow-up period: visual memory predicted improvement in daily living autonomy and in social competence; sustained attention predicted improvement in behavioral problems (such as medication compliance, collaboration with treatment providers or impulse control) and social competence; planning performances predicted improvement in social competence. These cognitive functions could be specifically targeted in a rehabilitation program aimed at enhancing functioning in those particular dimensions.

Entities:  

Mesh:

Year:  2005        PMID: 16085207     DOI: 10.1016/j.schres.2005.03.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  32 in total

1.  Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.

Authors:  Kathleen S Alexander; Hui-Qiu Wu; Robert Schwarcz; John P Bruno
Journal:  Psychopharmacology (Berl)       Date:  2011-10-26       Impact factor: 4.530

2.  The texture of the real: experimentation and experience in schizophrenia.

Authors:  Elizabeth Bromley
Journal:  Cult Med Psychiatry       Date:  2012-03

3.  Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation.

Authors:  Arielle W Tolman; Matthew M Kurtz
Journal:  Schizophr Bull       Date:  2010-07-11       Impact factor: 9.306

4.  The role of neurocognition and social context in predicting community functioning among formerly homeless seriously mentally ill persons.

Authors:  Russell K Schutt; Larry J Seidman; Brina Caplan; Anna Martsinkiv; Stephen M Goldfinger
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

Review 5.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

6.  Integrated psychological therapy (IPT) for schizophrenia: is it effective?

Authors:  Volker Roder; Daniel R Mueller; Kim T Mueser; Hans D Brenner
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

Review 7.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients.

Authors:  Caroline C Hilti; Tarik Delko; Ariane T Orosz; Kathrin Thomann; Stephan Ludewig; Mark A Geyer; Franz X Vollenweider; Joram Feldon; Katja Cattapan-Ludewig
Journal:  Neuropsychobiology       Date:  2009-12-12       Impact factor: 2.328

9.  Predictors of community functioning in schizophrenia and substance use disorder patients.

Authors:  Simon Zhornitsky; Ginette Aubin; Joelle Desfossés; Elie Rizkallah; Tania Pampoulova; Olivier Lipp; Jean-Pierre Chiasson; Emmanuel Stip; Stéphane Potvin
Journal:  Community Ment Health J       Date:  2012-07-31

10.  Structured floral arrangement programme for improving visuospatial working memory in schizophrenia.

Authors:  Hiroko Mochizuki-Kawai; Yuriko Yamakawa; Satoshi Mochizuki; Shoko Anzai; Masanobu Arai
Journal:  Neuropsychol Rehabil       Date:  2010-05-01       Impact factor: 2.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.